
Dr. Reddy's Laboratories Ltd. share price
NSE: DRREDDY · Healthcare
₹1,377.90 -0.15%
Closing price data, updated 17 Nov 2026. 52-week range: -2.6% from high, +25.1% above low.
Price₹1,377.90
Market cap₹1,14,778 Cr
P/E41.0
P/B2.97
ROE12.1%
ROCE14.2%
Debt / equity0.21
Dividend yield0.00%
EPS₹33.60
Book value₹463.61
Operating margin14.9%
Dipscan score49 / 100
Share: WhatsAppX / TwitterTelegram
Dr. Reddy's Laboratories Ltd. shareholding pattern
As of Sep 2026: Promoters 26.63%, FIIs 31.39%, DIIs 31.88%, Government 0.00%, Public 7.53%, Others 2.56%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 26.63% | 26.64% | 26.63% | 26.64% | 26.64% | 26.64% |
| FIIs | 31.39% | 32.07% | 33.08% | 33.20% | 35.52% | 36.36% |
| DIIs | 31.88% | 31.74% | 30.72% | 30.44% | 27.98% | 26.74% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 7.53% | 7.42% | 7.57% | 7.65% | 7.56% | 8.04% |
| Others | 2.56% | 2.13% | 1.99% | 2.07% | 2.30% | 2.22% |
| No. of Shareholders | 476,681 | 446,086 | 449,665 | 455,243 | 449,216 | 451,929 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| -0.15% | +0.36% | +13.31% | +14.25% | +5.70% | +13.74% |
Growth
| Sales growth, 3 years | +11.0% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | -1.7% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | -1.5% |
| Latest quarter profit vs last year | -35.6% |
Strengths and weaknesses
Strengths
- Company's working capital requirements have reduced from 85.1 days to 67.8 days
Weaknesses
- Dividend payout has been low at 13.2% of profits over last 3 years
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
| Mankind Pharma Ltd. | ₹2,626.60 | ₹1,08,490 Cr | 48.4 | 12.5% | +18.3% |
Frequently asked questions
What is the share price of Dr. Reddy's Laboratories Ltd.?
Dr. Reddy's Laboratories Ltd. (DRREDDY) last closed at ₹1,377.90 (-0.15% on the day).
What is the market cap of Dr. Reddy's Laboratories Ltd.?
About ₹1,14,778 Cr.
What is the P/E ratio of Dr. Reddy's Laboratories Ltd.?
The price-to-earnings ratio is 41.0, and return on equity is 12.1%.
Figures are calculated from company results and exchange prices and are for information only.